These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia. Khatib R; Jose J; Musta A; Sharma M; Fakih MG; Johnson LB; Riederer K; Shemes S J Antimicrob Chemother; 2011 Jul; 66(7):1594-9. PubMed ID: 21525024 [TBL] [Abstract][Full Text] [Related]
11. Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure. Kelley PG; Gao W; Ward PB; Howden BP J Antimicrob Chemother; 2011 May; 66(5):1057-60. PubMed ID: 21393156 [TBL] [Abstract][Full Text] [Related]
12. [Searching for Staphylococcus aureus strains with reduced susceptibility to glycopeptides among clinical isolates obtained during the year of 2002]. Młynarczyk A; Młynarczyk G; Łuczak M Med Dosw Mikrobiol; 2003; 55(3):209-17. PubMed ID: 14702662 [TBL] [Abstract][Full Text] [Related]
13. [Evaluation of reduced susceptibility to vancomycin among MRSA strains isolated from clinical specimens]. Aktaş E; Mengeloğlu FZ; Külah C; Cömert FB Mikrobiyol Bul; 2010 Apr; 44(2):339-41. PubMed ID: 20549970 [TBL] [Abstract][Full Text] [Related]
14. Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia. Sakoulas G; Gold HS; Cohen RA; Venkataraman L; Moellering RC; Eliopoulos GM J Antimicrob Chemother; 2006 Apr; 57(4):699-704. PubMed ID: 16464892 [TBL] [Abstract][Full Text] [Related]
15. Nationwide surveillance study of vancomycin intermediate Staphylococcus aureus strains in Korean hospitals from 2001 to 2006. Chung G; Cha J; Han S; Jang H; Lee K; Yoo J; Yoo J; Kim H; Eun S; Kim B; Park O; Lee Ys J Microbiol Biotechnol; 2010 Mar; 20(3):637-42. PubMed ID: 20372039 [TBL] [Abstract][Full Text] [Related]
16. Seeking vancomycin resistant Staphylococcus aureus among patients with vancomycin-resistant enterococci. Franchi D; Climo MW; Wong AH; Edmond MB; Wenzel RP Clin Infect Dis; 1999 Dec; 29(6):1566-8. PubMed ID: 10585815 [TBL] [Abstract][Full Text] [Related]
17. Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1997 Aug; 46(33):765-6. PubMed ID: 9272582 [TBL] [Abstract][Full Text] [Related]
18. Low colonization prevalence of Staphylococcus aureus with reduced vancomycin susceptibility among patients undergoing hemodialysis in the San Francisco Bay area. Eguia JM; Liu C; Moore M; Wrone EM; Pont J; Gerberding JL; Chambers HF Clin Infect Dis; 2005 Jun; 40(11):1617-24. PubMed ID: 15889359 [TBL] [Abstract][Full Text] [Related]